600062 logo

China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock Price

SHSE:600062 Community·CN¥19.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

600062 Share Price Performance

CN¥0
-19.58 (-100.00%)
CN¥0
-19.58 (-100.00%)
Price CN¥0

600062 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet established dividend payer.

1 Risk
5 Rewards

China Resources Double-Crane Pharmaceutical Co.,Ltd. Key Details

CN¥11.0b

Revenue

CN¥4.7b

Cost of Revenue

CN¥6.3b

Gross Profit

CN¥4.7b

Other Expenses

CN¥1.6b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 25, 2026
1.59
57.64%
14.97%
9.5%
View Full Analysis

About 600062

Founded
1939
Employees
13414
CEO
Qian Zhao
WebsiteView website
www.dcpc.com

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Recent 600062 News & Updates

Recent updates

No updates